5-Amino-1MQ vs SLU-PP-332

Name: 5-Amino-1MQ vs SLU-PP-332
Published: 2026-10-24

Updated Oct 24, 20268 sources

Key differences

1Both are small molecules sold beside peptides. 5-Amino-1MQ blocks the NNMT enzyme; SLU-PP-332 switches on ERR receptors.
2Both cut fat in obese mice without lowering food intake; neither has a human trial.

Facts from each record, in the same words as their own pages.

5-Amino-1MQ and SLU-PP-332 side by side
	5-Amino-1MQ	SLU-PP-332
Category	Weight loss, Longevity	Weight loss, Longevity
Evidence	Animal data only	Animal data only
FDA status	Not FDA approvedRegulatory	Not FDA approvedRegulatory
WADA	Prohibited	Not confirmed
Half-life	About 3.8 hours after IV and 6.9 hours after oral dosing in rats, with 38.4% oral bioavailability. No human data.Clinical study	No half-life published in any species. After a 30 mg/kg injection in mice it was still measurable in plasma and muscle 2 to 6 hours later.Clinical study One guide states about 1.5 hours in mice, without citing a study.Competitor guide
Routes	Oral, Subcutaneous injection	Subcutaneous injection, Oral
Forms	Not reported	Vial (powder), Tablet, Capsule, Oral solution
Reported doses	50 to 100 mg (oral) 2.5 to 50 mg (subcutaneous injection)	250 to 1,500 mcg (subcutaneous injection) 1 to 10 mg (subcutaneous injection) 5 to 100 mg (oral)
Most cited frequency	Once daily	Once daily; 500 mcg a day is a common example
Vial sizes	5 mg, 10 mg, 50 mgCompetitor guide	5 mg, 10 mg, 20 mgVendor guide
Mixed vial keeps	Keep the mixed vial at 2 to 8 °C, away from light, and use it within 2 to 4 weeks.Competitor guide	Fridge at 2 to 8 °C, protected from light.Competitor guide
Protocols on file	8	7

Doses shown are what sources report, labelled by origin. Not medical advice.

8 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.